IGC PHARMA, INC. Selling, General and Administrative Expense
IGC PHARMA, INC. (IGC) reported Selling, General and Administrative Expense of $1.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- IGC PHARMA, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $1.44M, a 19.37% increase year-over-year.
- IGC PHARMA, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $1.24M, a 117.72% increase year-over-year.
- IGC PHARMA, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.50M, a 33.01% increase year-over-year.
- IGC PHARMA, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.41M, a 35.45% increase year-over-year.
- IGC PHARMA, INC. selling, general and administrative expense for fiscal 2025 was $4.41M, a 34.74% decline from fiscal 2024.
- IGC PHARMA, INC. selling, general and administrative expense for fiscal 2024 was $6.76M, a 20.98% decline from fiscal 2023.
- IGC PHARMA, INC. selling, general and administrative expense for fiscal 2023 was $8.55M, a 35.66% decline from fiscal 2022.
- IGC PHARMA, INC. selling, general and administrative expense for fiscal 2022 was $13.29M, a 68.08% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.44M 10-Q · filed 2026-08-14 | $2.68M 10-Q · filed 2026-08-14 | $4.19M derived: sum of 3 quarters · filed 2026-08-14 | $5.60M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $1.24M 10-Q · filed 2026-05-15 | $2.74M derived: sum of 2 quarters · filed 2026-05-15 | $4.15M derived: sum of 3 quarters · filed 2026-05-15 | $5.36M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $1.50M derived: 10-KT 9 month − 10-Q 6 month · filed 2026-03-18 | $2.91M derived: sum of 2 quarters · filed 2026-03-18 | $4.12M 10-KT · filed 2026-03-18 | $4.69M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-09-30 | $1.41M 10-Q · filed 2025-11-14 | $2.62M 10-Q · filed 2025-11-14 | $3.19M derived: sum of 3 quarters · filed 2026-08-14 | $4.32M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $1.21M 10-Q · filed 2026-08-14 | $1.78M 10-Q · filed 2026-08-14 | $2.91M derived: sum of 3 quarters · filed 2026-08-14 | $3.95M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $570.00K 10-Q · filed 2026-05-15 | $1.70M derived: sum of 2 quarters · filed 2026-05-15 | $2.74M derived: sum of 3 quarters · filed 2026-05-15 | $4.41M 10-KT · filed 2026-03-18 | ||||
| 2024-12-31 | $1.13M 10-Q · filed 2025-02-14 | $2.17M derived: sum of 2 quarters · filed 2025-11-14 | $3.84M 10-KT · filed 2026-03-18 | $5.33M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-09-30 | $1.04M 10-Q · filed 2025-11-14 | $2.71M 10-Q · filed 2025-11-14 | $4.20M derived: sum of 3 quarters · filed 2025-11-14 | $6.42M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $1.67M 10-Q · filed 2025-08-14 | $3.16M derived: sum of 2 quarters · filed 2025-08-14 | $5.38M derived: sum of 3 quarters · filed 2025-08-14 | $6.78M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-27 | $3.71M derived: sum of 2 quarters · filed 2025-06-27 | $5.11M derived: sum of 3 quarters · filed 2025-06-27 | $6.76M 10-K · filed 2025-06-27 | ||||
| 2023-12-31 | $2.23M 10-Q · filed 2025-02-14 | $3.63M derived: sum of 2 quarters · filed 2025-02-14 | $5.27M 10-Q · filed 2025-02-14 | $8.88M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-09-30 | $1.40M 10-Q · filed 2024-11-12 | $3.04M 10-Q · filed 2024-11-12 | $6.65M derived: sum of 3 quarters · filed 2024-11-12 | $8.23M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $1.65M 10-Q · filed 2024-08-07 | $5.26M derived: sum of 2 quarters · filed 2024-08-07 | $6.83M derived: sum of 3 quarters · filed 2024-08-07 | $8.69M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | $5.18M derived: sum of 2 quarters · filed 2024-06-24 | $7.04M derived: sum of 3 quarters · filed 2024-06-24 | $8.55M 10-K · filed 2024-06-24 | ||||
| 2022-12-31 | $1.57M 10-Q · filed 2024-02-14 | $3.43M derived: sum of 2 quarters · filed 2024-02-14 | $4.94M 10-Q · filed 2024-02-14 | $10.31M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | $1.85M 10-Q · filed 2023-11-09 | $3.40M 10-Q · filed 2023-11-09 | $8.74M derived: sum of 3 quarters · filed 2023-11-09 | $10.81M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $1.55M 10-Q · filed 2023-08-10 | $6.89M derived: sum of 2 quarters · filed 2023-08-10 | $8.96M derived: sum of 3 quarters · filed 2023-08-10 | $13.07M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-07 | $7.41M derived: sum of 2 quarters · filed 2023-07-07 | $11.52M derived: sum of 3 quarters · filed 2023-07-07 | $13.29M 10-K · filed 2023-07-07 | ||||
| 2021-12-31 | $2.07M 10-Q · filed 2023-02-14 | $6.18M derived: sum of 2 quarters · filed 2023-02-14 | $7.96M 10-Q · filed 2023-02-14 | $10.44M derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | $4.11M 10-Q · filed 2022-11-01 | $5.89M 10-Q · filed 2022-11-01 | $8.37M derived: sum of 3 quarters · filed 2022-11-01 | $10.56M derived: sum of 4 quarters · filed 2022-11-01 | ||||
| 2021-06-30 | $1.78M 10-Q · filed 2022-08-05 | $4.26M derived: sum of 2 quarters · filed 2022-08-05 | $6.45M derived: sum of 3 quarters · filed 2022-08-05 | $7.93M derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | $4.67M derived: sum of 2 quarters · filed 2022-06-23 | $6.15M derived: sum of 3 quarters · filed 2022-06-23 | $7.91M 10-K · filed 2022-06-23 | ||||
| 2020-12-31 | $2.19M 10-Q · filed 2022-02-10 | $3.67M derived: sum of 2 quarters · filed 2022-02-10 | $5.42M 10-Q · filed 2022-02-10 | $7.64M derived: sum of 4 quarters · filed 2022-02-10 | ||||
| 2020-09-30 | $1.48M 10-Q · filed 2021-10-29 | $3.24M 10-Q · filed 2021-10-29 | $5.45M derived: sum of 3 quarters · filed 2021-10-29 | $6.86M derived: sum of 4 quarters · filed 2021-10-29 | ||||
| 2020-06-30 | $1.75M 10-Q · filed 2021-08-11 | $3.97M derived: sum of 2 quarters · filed 2021-08-11 | $5.38M derived: sum of 3 quarters · filed 2021-08-11 | $6.47M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-14 | $3.63M derived: sum of 2 quarters · filed 2021-06-14 | $4.72M derived: sum of 3 quarters · filed 2021-06-14 | $5.97M 10-K · filed 2021-06-14 | ||||
| 2019-12-31 | $1.41M 10-Q · filed 2021-02-16 | $2.51M derived: sum of 2 quarters · filed 2021-02-16 | $3.76M 10-Q · filed 2021-02-16 | $5.32M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | $1.09M 10-Q · filed 2020-11-20 | $2.34M 10-Q · filed 2020-11-20 | $3.91M derived: sum of 3 quarters · filed 2020-11-20 | $4.71M derived: sum of 4 quarters · filed 2020-11-20 | ||||
| 2019-06-30 | $1.25M 10-Q · filed 2020-08-19 | $2.81M derived: sum of 2 quarters · filed 2020-08-19 | $3.62M derived: sum of 3 quarters · filed 2020-08-19 | $4.21M derived: sum of 4 quarters · filed 2020-08-19 | ||||
| 2019-03-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-13 | $2.37M derived: sum of 2 quarters · filed 2020-07-13 | $2.97M derived: sum of 3 quarters · filed 2020-07-13 | $3.52M 10-K · filed 2020-07-13 | ||||
| 2018-12-31 | $807.00K 10-Q · filed 2020-02-10 | $1.40M derived: sum of 2 quarters · filed 2020-02-10 | $1.96M 10-Q · filed 2020-02-10 | $2.48M derived: sum of 4 quarters · filed 2020-02-10 | ||||
| 2018-09-30 | $595.00K 10-Q · filed 2019-11-06 | $873.00K 10-Q · filed 2018-10-16 | $1.15M 10-Q · filed 2019-11-06 | $1.43M 10-Q · filed 2018-10-16 | $1.67M derived: sum of 3 quarters · filed 2019-11-06 | $2.18M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2018-06-30 | $517.00K 10-Q · filed 2019-08-09 | $553.64K 10-Q · filed 2018-08-03 | $1.08M derived: sum of 2 quarters · filed 2019-08-09 | $1.59M derived: sum of 3 quarters · filed 2019-08-09 | $1.92M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-14 | $1.07M derived: sum of 2 quarters · filed 2019-06-14 | $1.41M derived: sum of 3 quarters · filed 2019-06-14 | $1.73M 10-K · filed 2019-06-14 | $1.87M 10-K · filed 2018-06-21 | |||
| 2017-12-31 | $512.00K 10-Q · filed 2019-02-12 | $507.33K 10-Q · filed 2018-02-20 | $847.00K derived: sum of 2 quarters · filed 2019-02-12 | $1.18M 10-Q · filed 2019-02-12 | $1.22M 10-Q · filed 2018-02-20 | $2.60M derived: sum of 4 quarters · filed 2019-02-12 | ||
| 2017-09-30 | $335.00K 10-Q · filed 2018-10-16 | $331.15K 10-Q · filed 2017-11-17 | $721.00K 10-Q · filed 2018-10-16 | $709.96K 10-Q · filed 2017-11-17 | $2.09M derived: sum of 3 quarters · filed 2018-10-16 | $2.41M derived: sum of 4 quarters · filed 2018-10-16 | ||
| 2017-06-30 | $442.31K 10-Q · filed 2018-08-03 | $436.35K 10-Q · filed 2017-08-18 | $1.75M derived: sum of 2 quarters · filed 2018-08-03 | $2.08M derived: sum of 3 quarters · filed 2018-08-03 | $2.42M derived: sum of 4 quarters · filed 2018-08-03 | |||
| 2017-03-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-21 | $1.63M derived: sum of 2 quarters · filed 2018-06-21 | $1.97M derived: sum of 3 quarters · filed 2018-06-21 | $2.27M 10-K · filed 2018-06-21 | $1.88M 10-K · filed 2017-07-14 | |||
| 2016-12-31 | $322.89K 10-Q · filed 2018-02-20 | $323.00K 10-Q · filed 2017-02-21 | $662.48K derived: sum of 2 quarters · filed 2018-02-20 | $959.69K 10-Q · filed 2018-02-20 | $960.00K 10-Q · filed 2017-02-21 | $2.41M derived: sum of 4 quarters · filed 2018-02-20 | ||
| 2016-09-30 | $339.58K 10-Q · filed 2017-11-17 | $636.80K 10-Q · filed 2017-11-17 | $2.08M derived: sum of 3 quarters · filed 2017-11-17 | $2.52M derived: sum of 4 quarters · filed 2017-11-17 | ||||
| 2016-06-30 | $307.77K 10-Q · filed 2017-08-18 | $1.74M derived: sum of 2 quarters · filed 2017-08-18 | $2.18M derived: sum of 3 quarters · filed 2017-08-18 | $2.71M derived: sum of 4 quarters · filed 2017-08-18 | ||||
| 2016-03-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-14 | $1.87M derived: sum of 2 quarters · filed 2017-07-14 | $2.40M derived: sum of 3 quarters · filed 2017-07-14 | $2.70M 10-K · filed 2017-07-14 | ||||
| 2015-12-31 | $438.00K 10-Q · filed 2017-02-21 | $437.72K 10-Q · filed 2016-02-16 | $963.35K derived: sum of 2 quarters · filed 2017-02-21 | $1.27M 10-Q · filed 2017-02-21 | $1.27M 10-Q · filed 2016-02-16 | $3.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-09-30 | $525.35K 10-Q · filed 2016-11-21 | $830.76K 10-Q · filed 2016-11-21 | $2.56M derived: sum of 3 quarters · filed 2016-11-21 | $3.10M derived: sum of 4 quarters · filed 2016-11-21 | ||||
| 2015-06-30 | $305.40K 10-Q · filed 2016-08-16 | $2.03M derived: sum of 2 quarters · filed 2016-08-16 | $2.58M derived: sum of 3 quarters · filed 2016-08-16 | $3.37M derived: sum of 4 quarters · filed 2016-08-16 | ||||
| 2015-03-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-14 | $2.27M derived: sum of 2 quarters · filed 2016-07-14 | $3.06M derived: sum of 3 quarters · filed 2016-07-14 | $4.14M 10-K · filed 2016-07-14 | ||||
| 2014-12-31 | $544.55K 10-Q · filed 2016-02-16 | $1.34M derived: sum of 2 quarters · filed 2016-02-16 | $2.41M 10-Q · filed 2016-02-16 | $3.66M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-09-30 | $791.43K 10-Q · filed 2015-11-13 | $1.87M 10-Q · filed 2015-11-13 | $3.12M derived: sum of 3 quarters · filed 2015-11-13 | $3.27M derived: sum of 4 quarters · filed 2015-11-13 | ||||
| 2014-06-30 | $1.08M 10-Q · filed 2015-08-14 | $2.33M derived: sum of 2 quarters · filed 2015-08-14 | $2.48M derived: sum of 3 quarters · filed 2015-08-14 | $2.96M derived: sum of 4 quarters · filed 2015-08-14 | ||||
| 2014-03-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-14 | $1.40M derived: sum of 2 quarters · filed 2015-07-14 | $1.88M derived: sum of 3 quarters · filed 2015-07-14 | $2.18M 10-K · filed 2015-07-14 | ||||
| 2013-12-31 | $156.05K 10-Q · filed 2015-02-12 | $631.00K derived: sum of 2 quarters · filed 2015-02-12 | $930.12K 10-Q · filed 2015-02-12 | $3.04M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-09-30 | $474.95K 10-Q · filed 2014-11-13 | $774.08K 10-Q · filed 2014-11-13 | $2.88M derived: sum of 3 quarters · filed 2014-11-13 | $3.03M derived: sum of 4 quarters · filed 2014-11-13 | ||||
| 2013-06-30 | $299.13K 10-Q · filed 2014-08-14 | $2.40M derived: sum of 2 quarters · filed 2014-08-14 | $2.56M derived: sum of 3 quarters · filed 2014-08-14 | $2.90M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $2.26M derived: sum of 2 quarters · filed 2014-07-15 | $2.60M derived: sum of 3 quarters · filed 2014-07-15 | $3.04M 10-K · filed 2014-07-15 | ||||
| 2012-12-31 | $153.79K 10-Q · filed 2014-02-14 | $495.57K derived: sum of 2 quarters · filed 2014-02-14 | $936.35K 10-Q · filed 2014-02-14 | $3.28M derived: sum of 4 quarters · filed 2014-07-15 | ||||
| 2012-09-30 | $341.78K 10-Q · filed 2013-11-08 | $782.56K 10-Q · filed 2013-11-08 | $3.13M derived: sum of 3 quarters · filed 2014-07-15 | $4.10M derived: sum of 4 quarters · filed 2014-07-15 | ||||
| 2012-06-30 | $440.77K 10-Q · filed 2013-08-16 | $2.79M derived: sum of 2 quarters · filed 2014-07-15 | $3.76M derived: sum of 3 quarters · filed 2014-07-15 | $4.41M derived: sum of 4 quarters · filed 2014-07-15 | ||||
| 2012-03-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $3.32M derived: sum of 2 quarters · filed 2014-07-15 | $3.97M derived: sum of 3 quarters · filed 2014-07-15 | $4.70M 10-K · filed 2014-07-15 | ||||
| 2011-12-31 | $968.89K 10-Q · filed 2013-02-13 | $1.62M derived: sum of 2 quarters · filed 2013-02-13 | $2.35M 10-Q · filed 2013-02-13 | $7.24M derived: sum of 4 quarters · filed 2013-02-13 | ||||
| 2011-09-30 | $652.38K 10-Q · filed 2012-11-14 | $1.39M 10-Q · filed 2012-11-14 | $6.27M derived: sum of 3 quarters · filed 2012-11-14 | $7.32M derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | $733.14K 10-Q/A · filed 2012-08-21 | $5.62M derived: sum of 2 quarters · filed 2012-08-21 | $6.67M derived: sum of 3 quarters · filed 2012-08-21 | $7.44M derived: sum of 4 quarters · filed 2012-08-21 | ||||
| 2011-03-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-16 | $5.94M derived: sum of 2 quarters · filed 2012-07-16 | $6.70M derived: sum of 3 quarters · filed 2012-07-16 | $7.28M 10-K · filed 2012-07-16 | ||||
| 2010-12-31 | $1.05M 10-Q · filed 2012-02-16 | $1.82M derived: sum of 2 quarters · filed 2012-02-16 | $2.40M 10-Q · filed 2012-02-16 | |||||
| 2010-09-30 | $763.71K 10-Q · filed 2011-11-18 | $1.34M 10-Q · filed 2011-11-18 | ||||||
| 2010-06-30 | $580.90K 10-Q · filed 2011-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |